Research Analysts Issue Forecasts for TSE:GUD Q2 Earnings
Knight Therapeutics Inc. (TSE:GUD – Free Report) – Stock analysts at Stifel Canada issued their Q2 2025 earnings per share estimates for Knight Therapeutics in a research note issued on Monday, March 24th. Stifel Canada analyst J. Keywood expects that the company will post earnings of $0.04 per share for the quarter. The consensus estimate […]
